Back

WuXi XDC achieves GMP release for Singapore site in two and a half years

Verifying
  • WuXi XDC held a GMP release ceremony for its Singapore manufacturing site.
  • DP4 offers annual capacity of up to 8 million liquid or lyophilized bioconjugate vials.
  • The site was announced in March 2024 and achieved GMP release in August 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.